Particular interaction between pyrimethamine derivatives and quadruple mutant type dihydrofolate reductase of Plasmodium falciparum: CoMFA and quantum chemical calculations studies

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 2, 2009, Pages 471-479

  Maitarad, Phornphimon ^a   Saparpakorn, Patchreenart ^a   Hannongbua, Supa ^a   Kamchonwongpaisan, Sumalee ^b   Tarnchompoo, Bongkoch ^b   Yuthavong, Yongyuth ^b  

^a KASETSART UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

CoMFA; Dihydrofolate reductae; Pyrimethamine; Quantum chemical calculations

Indexed keywords

ARGININE; ASPARAGINE; CARBON; CYSTEINE; DIHYDROFOLATE REDUCTASE; DIHYDROFOLATE REDUCTASE INHIBITOR; HYDROGEN; ISOLEUCINE; LEUCINE; OXYGEN; PYRIMETHAMINE; SERINE; ANTIMALARIAL AGENT; DRUG DERIVATIVE;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CALCULATION; COMPARATIVE MOLECULAR FIELD ANALYSIS; ENERGY; ENZYME INHIBITION; MOLECULAR INTERACTION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; QUANTUM CHEMISTRY; STEREOCHEMISTRY; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; COMPUTER SIMULATION; DRUG EFFECT; DRUG SENSITIVITY; ENZYMOLOGY; GENETICS; METABOLISM; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIMALARIALS; BINDING SITES; COMPUTER SIMULATION; MODELS, MOLECULAR; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROFOLATE DEHYDROGENASE; THERMODYNAMICS;

EID: 68049102138     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802201223     Document Type: Article

References (35)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. Estimating clinical episodes of malaria. Nature 2005;434: 214-217.
2. Prapunwattana P, Sirawaraporn W, Yuthavong Y, Santi DV. Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Mol Biochem Parasitol 1996;83:93-106.
3. Yuvaniyama J, Chitnumsub P, Kamchonwongpaisan S, Vanichtanankul J, Sirawaraporn W, Taylor P, Walkinshaw MD, Yuthavong Y. Insights into antifolate resistance from malarial DHFR-TS structures. Nat Struct Biol 2003;10:357-365.
4. Dasgupta T, Anderson KS. Probing the role of parasitespecific, distant structural regions on communication and catalysis in the bifunctional thymidylate synthase- dihydrofolate reductase from Plasmodium falciparum. Biochemistry 2008;47(5):1336-1345.
5. Delfino RT, Santos-Filho OA, Figueroa-Villar JD. Type2 antifolates in the chemotherapy of falciparum malaria. J Braz Chem Soc 2002;13:727-741.
6. Marbiah NT, Petersen E, David K, Magbity E, Lines J, Bradley DJ. A controlled trial of lambda-cyhalothrin-impregnated bed nets and/or dapsone/pyrimethamine for malaria control in Sierra Leone. Am J Trop Med Hyg 1998;58(1):1-6.
7. SowunmiA,Fateye BA, AdedejiAA,GbotoshoGO, HappiTC, Bamgboye AE, Bolaji OM, Oduola AMJ. Predictors of the failure of treatment with pyrimethamine- sulfadoxine in children with uncomplicated falciparum malaria. Acta Trop 2006;98:6-14.
8. Alker AP, Mwapasa V, Meshnick R. Rapid real-time PCR genotyping of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Antimicrob Agents Chemother 2004;48(8):2924-2929.
9. Warhurst DC. Resistance to antifolate in Plasmodium falciparum, the causative agent of tropical malaria. Sci Prog 2002;85:89-111.
10. Sirawaraporn W. Dihydrofolate reductase and antifolate resistance in malaria. Drug Resist Updat 1998;1:397-406.
11. Delfino RT, Santos-Filho OA, Figueroa-Villar JD. Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR. Biophys Chem 2002;98: 287-300.
12. Peterson DS, Milhous WK, Wellems TE. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 1990; 87:3018-3022.
13. Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 1997; 94:1124-1129.
14. Hastings IM, Donnelly MJ. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance. Drug Resist Updat 2005;8: 43-50.
15. Walliker D, Hunt P, Babiker H. Fitness of drug-resistant malaria parasites. Acta Trop 2005;94:251-259.
16. Kamchonwongpaisan S, Quarrell R, Charoensetakul N, Ponsinet R, Vilaivan T, Vanichtanankul J, Tarnchompoo B, SirawarapornW, Lowe G, Yuthavong Y. Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities. J Med Chem 2004;47:673-680.
17. Kubinyi H, Kubinyi H. QSAR: Hansch Analysis and Related Approaches VCH: Weinheim. 1993.
18. Hansch C, Leo A. Exploring QSAR. Fundamentals and Applications in Chemistry and Biology. Washington, DC: American Chemical Society; 1995.
19. Cramer RD, III, Patterson DE, Bunce JD. Comparative molecular field analysis CoMFA: 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc 1988;110: 5959-5967.
20. Kubinyi H, Flokers G, Martin YC. 3D QSAR in drug design: Ligand-protein interactions and molecular similarlity. Perspect Drug Discovery Des 1998;:3-398.
21. Sao SS, Karplus M. Evaluation of designed ligands by a multiple screening method: Application to glycogen phosphorylase inhibitors constructed with a variety of approaches. J Comput Aided Mol. Des 2001;15:613-647.
22. Saen-oon S, Kuno M, Hannongbua S. Binding energy analysis for wild-type and Y181C Mutant HIV-1 RT/8-Cl TIBO complex structures: Quantum chemical calculations based on the ONIOM method. PROTEINS: Structure, Function, and Bioinformatics 2005;61:859-869.
23. Kuno M, Hongkrengkai R, Hannongbua S. ONIOM-BSSE scheme for H-{ system and applications on HIV-1 reverse transcriptase. Chem Phys Lett 2006;424:172-177.
24. SYBYL 7.0., Tripos Associates Inc., 1699 South Hanley Road, Suite 303, St. Louis, Missouri 63144, USA.
25. Streitwieser A. Molecular Orbital Theory for Organic Chemists. Wiley: New York; 1961.
26. Clark M, Cramer RD, III. The probability of chance correlation using partial least squares (PLS). Quant Struct- Act Relat 1993;12(2):137-145.
27. Bush BL, Nachbar RB, Jr. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA. J Comput Aided Mol Des 1993;7:587-619.
28. Cho SJ, Tropsha A. Cross-validated R2-guided region selection for comparative molecular field analysis: A simple method to achieve consistent results. J Med Chem 1995;38: 1060-1066.
29. Golbraikh A, Tropsha A. Beware of q2!. J Mol Graph Mod 2002;20:269-276.
30. Hannongbua S, Nivesanond K, Lawtrakul L, Pungpo P, Wolschann P. 3D-quantitative structure-activity relationships of HEPT derivatives as HIV-1 reverse transcriptase inhibitors, based on ab initio calculations. J Chem Inf Comput Sci 2001; 41:848-855.
31. Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Jr., Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY,Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA. Gaussian 03, revision B.05; Gaussian, Inc.: Pittsburgh: 2003.
32. Boys SF, Bernardi F. The calculations of small molecular interaction by the difference of separate total energies some procedures with reduced error. Mol Phys 1970;19:553-566.
33. Yuthavong Y. Basis for antifolate action and resistance in malaria. Microb Inf 2002;4:175-182.
34. Rastelli G, Sirawaraporn W, Sompornpisut P, Vilaivan T, Kamchonwongpaisan S, Quarrell R,LoweG,ThebtaranonthY, Yuthavong Y. Interaction of pyrimethamine, cycloguanil, WR99210 and their Analogues with Plasmodium falciparum Dihydrofolate reductase: Structural basis of antifolate resistance. Bioorg Med Chem 2000;8:1117-1128.
35. Yuthavong Y, Yuvaniyama J, Chitnumsub P, Vanichtanankul J, Chusacultanachai S, Tarnchompoo B, Vilaivan T, Kamchonwongpaisan S. Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: Structural basis for antifolate resistance and development of effective inhibitors. Parasitology 2005;130:249-259.